Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785029 · ClinicalTrials.gov registry record
Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)
A clinical trial, sponsored by Heidelberg Engineering.
- Terminated
- Registry status
- 234
- Enrollment target
NCT02785029: Clinical Trial study, sponsored by Heidelberg Engineering.
NCT02785029 is a clinical trial that was terminated before completion, run by Heidelberg Engineering. The registered enrollment target is 234 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02785029 was terminated before completion, sponsored by Heidelberg Engineering.
- TERMINATED
- Registry status
- 234 participants
- Enrollment target
Study Summary
This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in African-American descent volunteers. The main goal of the study is to provide the range of these structural parameters in normal eyes.
Primary Outcome
Bruch-Membrane-Opening - Minimum Rim Width (µm)
Interventions
- DEVICE OCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2016-06 |
| Est. Completion | 2023-07 |
Why NCT02785029 stopped before completion
NCT02785029 is an observational study that tracks outcomes without assigning an intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which OCT is the first listed.
NCT02785029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02785029 about?
NCT02785029 is a clinical study titled "Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)". This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in African-American descent volunteers. The...
What is the current status of trial NCT02785029?
This trial is currently terminated. The enrollment target is 234 participants. The study started on 2016-06. Estimated completion is 2023-07.
What interventions are being tested in trial NCT02785029?
The interventions under investigation include: OCT (DEVICE).
Who is sponsoring clinical trial NCT02785029?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia